Who is replacing William B. Rutherford as CFO and Principal Accounting Officer?

William B. Rutherford is retiring as Executive Vice President and Chief Financial Officer effective May 1, 2024. Christopher F. Wyatt, who currently serves as Senior Vice President and Controller, will succeed Mr. Rutherford as the principal accounting officer, effective May 1, 2024. The report does not indicate a replacement for the CFO role specifically.

What was the outcome of the director elections at the Annual Meeting?

All ten director nominees presented at the Annual Meeting were overwhelmingly elected to the Company's Board of Directors for a one-year term. The voting results show substantial 'For' votes for each nominee, indicating strong stockholder confidence in the current board composition.

What is the significance of the 'Say-on-Pay' vote outcome?

The Company's stockholders approved a non-binding advisory resolution to hold an advisory vote on the compensation of the Company's named executive officers every year. The Board of Directors has accepted this determination, meaning investors will have an annual opportunity to vote on executive compensation.

Were any of the stockholder proposals approved at the meeting?

No, all seven stockholder proposals presented at the Annual Meeting, which covered topics such as risk mitigation for abortion restrictions, patient feedback on care quality, and maternal health outcomes, were not approved by a significant margin.

HCA 8-K: Leadership Changes & Shareholder Matters

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K report on April 29, 2024, detailing key events from its Annual Meeting of Stockholders held on April 25, 2024, and a CFO transition. The report announced the retirement of Executive Vice President and CFO William B. Rutherford, effective May 1, 2024, with Christopher F. Wyatt appointed as the new principal accounting officer while continuing his role as Senior Vice President and Controller. This transition appears smooth with no immediate concerns indicated regarding Mr. Wyatt's appointment. The Annual Meeting saw strong stockholder support for the re-election of all ten director nominees and the ratification of Ernst & Young LLP as the independent registered public accounting firm. Furthermore, stockholders approved a non-binding advisory resolution to hold annual say-on-pay votes, aligning with the board's determination to conduct these votes yearly. Conversely, several stockholder proposals concerning risk mitigation for state restrictions on emergency abortions, patient feedback on care quality, and maternal health outcomes were not approved.

Key Highlights

1William B. Rutherford, EVP and CFO, to retire effective May 1, 2024; Christopher F. Wyatt appointed Principal Accounting Officer.
2Christopher F. Wyatt will continue to serve as Senior Vice President and Controller.
3All ten director nominees were overwhelmingly elected to the Board of Directors.
4Ernst & Young LLP was ratified as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
5Stockholders approved holding an annual advisory vote on executive compensation ('Say-on-Pay').
6All stockholder proposals related to abortion risk mitigation, patient feedback, and maternal health outcomes were not approved.

HCA Healthcare, Inc. 8-K Report, Executive Changes (Apr 30, 2024)

Summary

Key Highlights

Frequently Asked Questions